Ulcerative Colitis
The HORIZON Study is looking to find out more about an investigational study drug for adults with moderate to severe ulcerative colitis (UC). This study will specifically enroll adults who have tried at least 1 previous therapy for UC that did not work. The investigational study drug is designed to block 2 proteins in the body that contribute to the inflammation that is thought to lead to people getting UC. The purpose of this study is to compare the safety and effectiveness of the investigational study drug to an approved drug for the treatment of UC. Participants will not know if they receive the investigational study drug or the approved drug.
If you are suffering from moderately to severely active UC and are interested in participating in the ALTB-268-201 Clinical Trial, ask your doctor for more information. Your doctor will be able to tell you more about the study and answer any questions you may have. If you decide to participate in this trial, your doctor will discuss an Informed Consent Form with you.